The size of the Oxygen Therapy Market in Europe was worth USD 0.56 billion in 2019 and estimated to be growing at a CAGR of 5.77%, to reach USD 0.74 billion by 2024.
Oxygen Therapy devices are useful especially for people suffering from severe COPD or cystic fibrosis who suffer from chronically low oxygen levels in their bodies. The advantages of oxygen therapy also include increased mental stamina, aversion of heart failure, and an enhanced breathing pattern. The administration and supply of supplementary oxygen have turned into an indispensable part in the management of numerous diseases. Furthermore, oxygen therapy is applicable to numerous diseases, for example, asthma, respiratory distress syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in patients suffering from chronic lung disease are believed to enhance the length and quality of life.
In Europe, the prevalence of COPD varies markedly across countries. For example, the Ministère de la Santé et des Solidaritiés estimates that between 6% and 8% of the adult population in France suffers from COPD. Interestingly, the Netherlands displays just a 2% prevalence rate as evaluated by the National Institute for Public Health and the Environment. Generally, these devices are used to treat patients who are no longer able to receive adequate volumes of oxygen through the breathing of natural air and require higher concentrations of oxygen. A significant increase is expected in the number of patients on oxygen therapy as the population ages and as members of the 50 to 75 age demographics, who were often smokers in their youth, develop emphysema and related conditions. It is estimated that over 85% of the patients on oxygen therapy are, or were, once smokers.
This research report has been segmented & sub-segmented into the following categories:
Regionally, Europe has the second-highest revenue in the oxygen therapy devices market and is expected to grow further in the coming years. Favorable government policies and initiatives such as the Europe Committee for Hyperbaric Medicine (ECHM), involved in promoting awareness pertaining to the treatment and thereby promoting the growth of the oxygen therapy devices market.
Companies leading the EU Oxygen Therapy Market are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc. and Respan Products Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Oxygen Source Equipment
5.1.2.1 Oxygen Concentrators
5.1.2.1.1 Fixed Oxygen Concentrators
5.1.2.1.2 Portable Oxygen Concentrators
5.1.2.2 Liquid Oxygen Devices
5.1.2.3 Oxygen Cylinders
5.1.3 Oxygen Delivery Devices
5.1.3.1 Oxygen Masks
5.1.3.2 Nasal Cannulas
5.1.3.3 Venturi Masks
5.1.3.4 Non-Rebreather Masks
5.1.3.5 Bag Valve Masks
5.1.3.6 Other Devices
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Portability
5.2.1 Introduction
5.2.2 Stationary Oxygen Therapy Devices
5.2.3 Portable Oxygen Therapy Devices
5.2.4 Y-o-Y Growth Analysis, By Portability
5.2.5 Market Attractiveness Analysis, By Portability
5.2.6 Market Share Analysis, By Portability
5.3 Application
5.3.1 Introduction
5.3.2 Chronic Obstructive Pulmonary Disease
5.3.3 Asthma, Obstructive Sleep Apnea
5.3.4 Respiratory Distress Syndrome
5.3.5 Cystic Fibrosis
5.3.6 Pneumonia
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Home Care Settings
5.4.3 Hospitals
5.4.4 Ambulatory Surgical Centers & Physician Offices
5.4.5 Others
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Portability
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Portability
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Portability
6.1.5.4 By Application
6.1.5.5 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Respironics Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Teleflex Incorporated
8.3 AirSep Corporation
8.4 DeVilbiss Healthcare
8.5 ResMed Inc
8.6 Fisher & Paykel Healthcare Limited
8.7 Invacare
8.8 Essex Industries Inc.
8.9 HERSILL S.L.
8.10 Weinmann Emergency Medical Technology
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
